Showing results (111-120 of 180) with videos related to
Sort By:
Pageof 18
Alimentary Pharmacology & Therapeutics|December 29, 2018
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infectionTung-Hung Su, Chun-Jen Liu, Tai-Chung Tseng, et al.Hepatology (Baltimore, Md.)|December 15, 2015
Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort studyTung-Hung Su, Chun-Jen Liu, Tai-Chung Tseng, et al.World Journal of Emergency Surgery : WJES|January 7, 2014
Risk factors for late death of patients with abdominal trauma after damage control laparotomy for hemostasisLi-Min Liao, Chih-Yuan Fu, Shang-Yu Wang, et al.Biochemical and Biophysical Research Communications|October 20, 2024
Characterization of anti-EBNA-1 antibodies and exploration of their molecular mimicry potential in an EBV-infected Sjögren's syndrome patientShang-Ju Hsieh, Tsung-Hsun Tsai, Jiun-Han Lin, et al.Plos One|December 24, 2014
Visualization of subunit interactions and ternary complexes of protein phosphatase 2A in mammalian cellsShu-Ting Mo, Shang-Ju Chiang, Tai-Yu Lai, et al.Leukemia Research|December 28, 2025
Clinical characteristics, treatment pathway and resource utilisation for patients with chronic lymphocytic leukaemia: A multicentre retrospective studyAhmad Alhuraiji, Ayman Alhejazi, Bhausaheb Bagal, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 26, 2008
Clinical characteristics and treatment response of Hodgkin's lymphoma in TaiwanShang-Ju Wu, Chien-Yuan Chen, Ih-Jen Su, et al.Leukemia & Lymphoma|October 11, 2021
Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trialTara Cochrane, Alicia Enrico, David Gomez-Almaguer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2026
Rituximab, Acalabrutinib, and Durvalumab for Primary Central Nervous System Lymphoma: A Single-arm, Phase 1b, Multi-center StudyKwang-Yu Chang, Ya-Ting Hsu, Shih-Sung Chuang, et al.Frontiers in Pharmacology|February 6, 2024
Efficacy and pharmacoeconomic advantages of Fufang Huangbai Fluid hydropathic compress in diabetic foot infections: a comparative clinical study with antimicrobial calcium alginate wound dressingGuangyao Yang, Gang Wang, Zhenghong Li, et al.Pageof 18